Stewardship Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$332K Buy
287
+23
+9% +$27.1K 0.07% 127
2026
Q2
$317K Buy
264
+18
+7% +$18.4K 0.07% 136
2026
Q1
$226K Sell
246
-23
-9% -$23.3K 0.05% 152
2025
Q4
$289K Buy
+269
New +$257K 0.07% 119

Other funds holding LLY

Stewardship Advisors's LLY Position: Q3 2026 in Review

Stewardship Advisors increased its Eli Lilly (LLY) stake by 8.7% in Q3 2026, buying an estimated $27.1K and bringing the position to 287 shares worth $332K. The position accounts for 0.07% of the portfolio, ranked #127.

Stewardship Advisors first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. 3,304 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Stewardship Advisors held 287 shares of Eli Lilly worth $332K as of Q3 2026.
  • Stewardship Advisors bought 23 Eli Lilly shares in Q3 2026, an estimated $27.1K.
  • Eli Lilly made up 0.07% of Stewardship Advisors's portfolio in Q3 2026, its #127 holding.
  • Stewardship Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • 3,304 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Stewardship Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.